{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,20]],"date-time":"2026-10-20T14:40:26Z","timestamp":1792507226266,"version":"4.5.0"},"reference-count":84,"publisher":"Rockefeller University Press","issue":"11","license":[{"start":{"date-parts":[[2026,10,20]],"date-time":"2026-10-20T00:00:00Z","timestamp":1792454400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["K08-CA245251"],"award-info":[{"award-number":["K08-CA245251"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["R37-CA286444"],"award-info":[{"award-number":["R37-CA286444"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["R01-CA296556"],"award-info":[{"award-number":["R01-CA296556"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["P30-CA021765"],"award-info":[{"award-number":["P30-CA021765"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["R01-CA275187"],"award-info":[{"award-number":["R01-CA275187"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100012524","name":"American Lebanese Syrian Associated Charities","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100012524","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100007737","name":"St. Jude Children\u2019s Research Hospital","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100007737","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100013114","name":"Broad Institute of MIT and Harvard","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100013114","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100007886","name":"Dana-Farber Cancer Institute","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100007886","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100001445","name":"Alex\u2019s Lemonade Stand Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100001445","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100003287","name":"Rally Foundation for Childhood Cancer Research","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100003287","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100016615","name":"Curing Kids Cancer Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100016615","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100001368","name":"V Foundation for Cancer Research","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100001368","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100008258","name":"Hyundai Hope on Wheels Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100008258","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004099","name":"La Ligue Contre le Cancer","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004099","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["rupress.org"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2026,11,2]]},"abstract":"<jats:p>Cancers depend on transcriptional control to maintain the malignant cell state. EP300 and CBP are paralogous master epigenetic enzymes that control normal and malignant transcription. Using a cancer-wide integrative chemical-genetic analysis, we demonstrate enhanced dependency on EP300, compared with CBP, in cell lines from most cancer lineages, including lethal osteosarcoma (OS). Using a selective EP300 degrader (JQAD1), we identify that a genetically defined subgroup of OS with dysregulation of the PI3K\u2013AKT\u2013mTOR pathway is genetically and chemically sensitive to loss of EP300. Activated AKT promotes sensitivity to JQAD1, driven by relocalization of EP300, CBP and H3K27ac to genetic subtype-enriched dependency loci. AKT inhibition combines with JQAD1 to synergistically suppress the growth of AKT-dysregulated OS cells in vitro and in orthotopic xenografts. These observations extend across &amp;gt;850 cancer cell lines, where synergy is predicted by elevated protein synthetic rates. These findings reveal determinants of EP300 degrader function in OS and provide a foundation for co-targeting EP300 and AKT in cancers with enhanced protein translation.<\/jats:p>","DOI":"10.1084\/jem.20251898","type":"journal-article","created":{"date-parts":[[2026,10,20]],"date-time":"2026-10-20T13:51:06Z","timestamp":1792504266000},"update-policy":"https:\/\/doi.org\/10.1084\/jem.crossmarkpolicy","source":"Crossref","is-referenced-by-count":0,"title":["Dysregulated AKT signaling reprograms osteosarcoma to drive selective reliance on EP300"],"prefix":"10.1084","volume":"223","author":[{"given":"Ian M.","family":"Delahunty","sequence":"first","affiliation":[{"id":[{"id":"https:\/\/ror.org\/02r3e0967","id-type":"ROR","asserted-by":"publisher"}],"name":"St. Jude Children\u2019s Research Hospital 1 Division of Molecular Oncology, Department of Oncology, , Memphis, TN,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0007-9597-2134","authenticated-orcid":true,"given":"Stephanie","family":"Nance","sequence":"additional","affiliation":[{"id":[{"id":"https:\/\/ror.org\/02r3e0967","id-type":"ROR","asserted-by":"publisher"}],"name":"St. Jude Children\u2019s Research Hospital 1 Division of Molecular Oncology, Department of Oncology, , Memphis, TN,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1712-7211","authenticated-orcid":true,"given":"Yang","family":"Zhang","sequence":"additional","affiliation":[{"id":[{"id":"https:\/\/ror.org\/02r3e0967","id-type":"ROR","asserted-by":"publisher"}],"name":"St. Jude Children\u2019s Research Hospital 2 Department of Computational Biology, , Memphis, TN,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2738-0758","authenticated-orcid":true,"given":"Francois","family":"Lamoureux","sequence":"additional","affiliation":[{"name":"Nantes Universit\u00e9 3 , INSERM UMR 1307, CNRS UMR 6075, CRCI2NA, Nantes,","place":["France"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4100-9509","authenticated-orcid":true,"given":"Qi","family":"Liu","sequence":"additional","affiliation":[{"id":[{"id":"https:\/\/ror.org\/02jzgtq86","id-type":"ROR","asserted-by":"publisher"}],"name":"Dana-Farber Cancer Institute 4 Department of Cancer Biology, , Department of Medicine, Harvard Medical School, Boston, MA,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2274-9966","authenticated-orcid":true,"given":"William C.","family":"Wright","sequence":"additional","affiliation":[{"id":[{"id":"https:\/\/ror.org\/02r3e0967","id-type":"ROR","asserted-by":"publisher"}],"name":"St. Jude Children\u2019s Research Hospital 2 Department of Computational Biology, , Memphis, TN,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5586-5154","authenticated-orcid":true,"given":"K. Elaine","family":"Ritter","sequence":"additional","affiliation":[{"id":[{"id":"https:\/\/ror.org\/02r3e0967","id-type":"ROR","asserted-by":"publisher"}],"name":"St. Jude Children\u2019s Research Hospital 1 Division of Molecular Oncology, Department of Oncology, , Memphis, TN,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4765-6774","authenticated-orcid":true,"given":"Noha A.M.","family":"Shendy","sequence":"additional","affiliation":[{"id":[{"id":"https:\/\/ror.org\/02r3e0967","id-type":"ROR","asserted-by":"publisher"}],"name":"St. Jude Children\u2019s Research Hospital 1 Division of Molecular Oncology, Department of Oncology, , Memphis, TN,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4556-9853","authenticated-orcid":true,"given":"B\u00e9n\u00e9dicte","family":"Brounais-Le Roye","sequence":"additional","affiliation":[{"name":"Nantes Universit\u00e9 3 , INSERM UMR 1307, CNRS UMR 6075, CRCI2NA, Nantes,","place":["France"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5775-559X","authenticated-orcid":true,"given":"Sandra J.","family":"Kietlinska","sequence":"additional","affiliation":[{"id":[{"id":"https:\/\/ror.org\/02r3e0967","id-type":"ROR","asserted-by":"publisher"}],"name":"St. Jude Children\u2019s Research Hospital 1 Division of Molecular Oncology, Department of Oncology, , Memphis, TN,","place":["USA"]},{"id":[{"id":"https:\/\/ror.org\/02r3e0967","id-type":"ROR","asserted-by":"publisher"}],"name":"St. Jude Graduate School of Biomedical Sciences, St. Jude Children\u2019s Research Hospital 5 , Memphis, TN,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6022-6632","authenticated-orcid":true,"given":"Mohammad A.","family":"Mohammad Nezhady","sequence":"additional","affiliation":[{"id":[{"id":"https:\/\/ror.org\/02r3e0967","id-type":"ROR","asserted-by":"publisher"}],"name":"St. Jude Children\u2019s Research Hospital 1 Division of Molecular Oncology, Department of Oncology, , Memphis, TN,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0007-8932-4405","authenticated-orcid":true,"given":"Yuan","family":"Feng","sequence":"additional","affiliation":[{"id":[{"id":"https:\/\/ror.org\/02r3e0967","id-type":"ROR","asserted-by":"publisher"}],"name":"St. Jude Children\u2019s Research Hospital 2 Department of Computational Biology, , Memphis, TN,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4194-234X","authenticated-orcid":true,"given":"Barbara","family":"De Kegel","sequence":"additional","affiliation":[{"id":[{"id":"https:\/\/ror.org\/05a0ya142","id-type":"ROR","asserted-by":"publisher"}],"name":"Broad Institute of MIT and Harvard 6 , Cambridge, MA,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2987-7581","authenticated-orcid":true,"given":"Matthew G.","family":"Rees","sequence":"additional","affiliation":[{"id":[{"id":"https:\/\/ror.org\/05a0ya142","id-type":"ROR","asserted-by":"publisher"}],"name":"Broad Institute of MIT and Harvard 6 , Cambridge, MA,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0003-9681-5975","authenticated-orcid":true,"given":"Mustafa","family":"Kocak","sequence":"additional","affiliation":[{"id":[{"id":"https:\/\/ror.org\/05a0ya142","id-type":"ROR","asserted-by":"publisher"}],"name":"Broad Institute of MIT and Harvard 6 , Cambridge, MA,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6923-3596","authenticated-orcid":true,"given":"Ashish B.","family":"George","sequence":"additional","affiliation":[{"id":[{"id":"https:\/\/ror.org\/05a0ya142","id-type":"ROR","asserted-by":"publisher"}],"name":"Broad Institute of MIT and Harvard 6 , Cambridge, MA,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0007-9828-0694","authenticated-orcid":true,"given":"Meifen","family":"Lu","sequence":"additional","affiliation":[{"id":[{"id":"https:\/\/ror.org\/02r3e0967","id-type":"ROR","asserted-by":"publisher"}],"name":"St. Jude Children\u2019s Research Hospital 7 Department of Pathology, , Memphis, TN,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3874-3101","authenticated-orcid":true,"given":"Anoop M.","family":"Kavirayani","sequence":"additional","affiliation":[{"id":[{"id":"https:\/\/ror.org\/02r3e0967","id-type":"ROR","asserted-by":"publisher"}],"name":"St. Jude Children\u2019s Research Hospital 7 Department of Pathology, , Memphis, TN,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0005-0756-2019","authenticated-orcid":true,"given":"Bo","family":"Wang","sequence":"additional","affiliation":[{"id":[{"id":"https:\/\/ror.org\/02r3e0967","id-type":"ROR","asserted-by":"publisher"}],"name":"St. Jude Children\u2019s Research Hospital 2 Department of Computational Biology, , Memphis, TN,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4244-2742","authenticated-orcid":true,"given":"Yanling","family":"Liu","sequence":"additional","affiliation":[{"id":[{"id":"https:\/\/ror.org\/02r3e0967","id-type":"ROR","asserted-by":"publisher"}],"name":"St. Jude Children\u2019s Research Hospital 2 Department of Computational Biology, , Memphis, TN,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0000-5019-6943","authenticated-orcid":true,"given":"Paris E.A.","family":"Prinsen","sequence":"additional","affiliation":[{"id":[{"id":"https:\/\/ror.org\/02r3e0967","id-type":"ROR","asserted-by":"publisher"}],"name":"St. Jude Children\u2019s Research Hospital 1 Division of Molecular Oncology, Department of Oncology, , Memphis, TN,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0008-6338-2583","authenticated-orcid":true,"given":"Yousef","family":"Khashana","sequence":"additional","affiliation":[{"id":[{"id":"https:\/\/ror.org\/02r3e0967","id-type":"ROR","asserted-by":"publisher"}],"name":"St. Jude Children\u2019s Research Hospital 1 Division of Molecular Oncology, Department of Oncology, , Memphis, TN,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1898-6555","authenticated-orcid":true,"given":"Vernon Justice","family":"Ebegboni","sequence":"additional","affiliation":[{"id":[{"id":"https:\/\/ror.org\/02r3e0967","id-type":"ROR","asserted-by":"publisher"}],"name":"St. Jude Children\u2019s Research Hospital 1 Division of Molecular Oncology, Department of Oncology, , Memphis, TN,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4269-1404","authenticated-orcid":true,"given":"Melissa M.","family":"Ronan","sequence":"additional","affiliation":[{"id":[{"id":"https:\/\/ror.org\/05a0ya142","id-type":"ROR","asserted-by":"publisher"}],"name":"Broad Institute of MIT and Harvard 6 , Cambridge, MA,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5117-5586","authenticated-orcid":true,"given":"Jennifer A.","family":"Roth","sequence":"additional","affiliation":[{"id":[{"id":"https:\/\/ror.org\/05a0ya142","id-type":"ROR","asserted-by":"publisher"}],"name":"Broad Institute of MIT and Harvard 6 , Cambridge, MA,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9787-9351","authenticated-orcid":true,"given":"E. Alejandro","family":"Sweet-Cordero","sequence":"additional","affiliation":[{"id":[{"id":"https:\/\/ror.org\/043mz5j54","id-type":"ROR","asserted-by":"publisher"}],"name":"University of California San Francisco 8 Division of Pediatric Oncology, Department of Pediatrics, , San Francisco, CA,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5906-7504","authenticated-orcid":true,"given":"Lillian M.","family":"Guenther","sequence":"additional","affiliation":[{"id":[{"id":"https:\/\/ror.org\/02r3e0967","id-type":"ROR","asserted-by":"publisher"}],"name":"St. Jude Children\u2019s Research Hospital 1 Division of Molecular Oncology, Department of Oncology, , Memphis, TN,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5128-0087","authenticated-orcid":true,"given":"Paul","family":"Geeleher","sequence":"additional","affiliation":[{"id":[{"id":"https:\/\/ror.org\/02r3e0967","id-type":"ROR","asserted-by":"publisher"}],"name":"St. Jude Children\u2019s Research Hospital 2 Department of Computational Biology, , Memphis, TN,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6233-2145","authenticated-orcid":true,"given":"Xiaotu","family":"Ma","sequence":"additional","affiliation":[{"id":[{"id":"https:\/\/ror.org\/02r3e0967","id-type":"ROR","asserted-by":"publisher"}],"name":"St. Jude Children\u2019s Research Hospital 2 Department of Computational Biology, , Memphis, TN,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2622-7356","authenticated-orcid":true,"given":"Benjamin","family":"Ory","sequence":"additional","affiliation":[{"name":"Nantes Universit\u00e9 3 , INSERM UMR 1307, CNRS UMR 6075, CRCI2NA, Nantes,","place":["France"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1461-3356","authenticated-orcid":true,"given":"Jun","family":"Qi","sequence":"additional","affiliation":[{"id":[{"id":"https:\/\/ror.org\/02jzgtq86","id-type":"ROR","asserted-by":"publisher"}],"name":"Dana-Farber Cancer Institute 4 Department of Cancer Biology, , Department of Medicine, Harvard Medical School, Boston, MA,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8085-3027","authenticated-orcid":true,"given":"Brian J.","family":"Abraham","sequence":"additional","affiliation":[{"id":[{"id":"https:\/\/ror.org\/02r3e0967","id-type":"ROR","asserted-by":"publisher"}],"name":"St. Jude Children\u2019s Research Hospital 2 Department of Computational Biology, , Memphis, TN,","place":["USA"]},{"id":[{"id":"https:\/\/ror.org\/02r3e0967","id-type":"ROR","asserted-by":"publisher"}],"name":"St. Jude Graduate School of Biomedical Sciences, St. Jude Children\u2019s Research Hospital 5 , Memphis, TN,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5472-9847","authenticated-orcid":true,"given":"Adam D.","family":"Durbin","sequence":"additional","affiliation":[{"id":[{"id":"https:\/\/ror.org\/02r3e0967","id-type":"ROR","asserted-by":"publisher"}],"name":"St. Jude Children\u2019s Research Hospital 1 Division of Molecular Oncology, Department of Oncology, , Memphis, TN,","place":["USA"]},{"id":[{"id":"https:\/\/ror.org\/02r3e0967","id-type":"ROR","asserted-by":"publisher"}],"name":"St. Jude Graduate School of Biomedical Sciences, St. Jude Children\u2019s Research Hospital 5 , Memphis, TN,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"291","published-online":{"date-parts":[[2026,10,20]]},"reference":[{"key":"2026102009504713200_bib1","doi-asserted-by":"publisher","first-page":"818","DOI":"10.1158\/2159-8290.CD-17-0151","article-title":"AACR project GENIE: Powering precision medicine through an international consortium","volume":"7","author":"AACR Project GENIE Consortium","year":"2017","journal-title":"Cancer Discov."},{"key":"2026102009504713200_bib2","doi-asserted-by":"publisher","first-page":"9354","DOI":"10.1038\/s41598-019-45839-z","article-title":"The ENCODE blacklist: Identification of problematic regions of the genome","volume":"9","author":"Amemiya","year":"2019","journal-title":"Sci. Rep."},{"key":"2026102009504713200_bib3","doi-asserted-by":"publisher","first-page":"166","DOI":"10.1093\/bioinformatics\/btu638","article-title":"HTSeq--a Python framework to work with high-throughput sequencing data","volume":"31","author":"Anders","year":"2015","journal-title":"Bioinformatics"},{"key":"2026102009504713200_bib4","doi-asserted-by":"publisher","first-page":"799","DOI":"10.1016\/0092-8674(94)90127-9","article-title":"E1A-associated p300 and CREB-associated CBP belong to a conserved family of coactivators","volume":"77","author":"Arany","year":"1994","journal-title":"Cell"},{"key":"2026102009504713200_bib5","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1038\/s41467-025-67171-z","article-title":"EP300 deficiency leads to chronic replication stress mediated by defective replication fork protection","volume":"17","author":"Barreto-Galvez","year":"2025","journal-title":"Nat. Commun."},{"key":"2026102009504713200_bib6","doi-asserted-by":"publisher","first-page":"104","DOI":"10.1016\/j.celrep.2014.03.003","article-title":"Recurrent somatic structural variations contribute to tumorigenesis in pediatric osteosarcoma","volume":"7","author":"Chen","year":"2014","journal-title":"Cell Rep."},{"key":"2026102009504713200_bib7","doi-asserted-by":"publisher","first-page":"3094","DOI":"10.1021\/jacsau.4c00442","article-title":"Paralogue-selective degradation of the lysine acetyltransferase EP300","volume":"4","author":"Chen","year":"2024","journal-title":"JACS Au"},{"key":"2026102009504713200_bib8","doi-asserted-by":"publisher","first-page":"527","DOI":"10.1038\/nmeth.3394","article-title":"CONSERTING: Integrating copy-number analysis with structural-variation detection","volume":"12","author":"Chen","year":"2015","journal-title":"Nat. Methods"},{"key":"2026102009504713200_bib9","doi-asserted-by":"publisher","first-page":"265","DOI":"10.1038\/s41571-023-00736-3","article-title":"Protein degraders enter the clinic - a new approach to cancer therapy","volume":"20","author":"Chirnomas","year":"2023","journal-title":"Nat. Rev. Clin. Oncol."},{"key":"2026102009504713200_bib10","doi-asserted-by":"publisher","first-page":"440","DOI":"10.1158\/0008-5472.CAN-09-1947","article-title":"Drug combination studies and their synergy quantification using the Chou-Talalay method","volume":"70","author":"Chou","year":"2010","journal-title":"Cancer Res."},{"key":"2026102009504713200_bib11","doi-asserted-by":"publisher","first-page":"235","DOI":"10.1038\/s43018-019-0018-6","article-title":"Discovering the anti-cancer potential of non-oncology drugs by systematic viability profiling","volume":"1","author":"Corsello","year":"2020","journal-title":"Nat. Cancer"},{"key":"2026102009504713200_bib12","doi-asserted-by":"publisher","first-page":"21931","DOI":"10.1073\/pnas.1016071107","article-title":"Histone H3K27ac separates active from poised enhancers and predicts developmental state","volume":"107","author":"Creyghton","year":"2010","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"2026102009504713200_bib13","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1186\/s13059-020-02254-2","article-title":"SequencErr: Measuring and suppressing sequencer errors in next-generation sequencing data","volume":"22","author":"Davis","year":"2021","journal-title":"Genome Biol."},{"key":"2026102009504713200_bib14","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1016\/j.cell.2012.06.013","article-title":"Cancer epigenetics: From mechanism to therapy","volume":"150","author":"Dawson","year":"2012","journal-title":"Cell"},{"key":"2026102009504713200_bib15","doi-asserted-by":"publisher","first-page":"647","DOI":"10.1056\/NEJMra1112635","article-title":"Targeting epigenetic readers in cancer","volume":"367","author":"Dawson","year":"2012","journal-title":"N. Engl. J. Med."},{"key":"2026102009504713200_bib16","doi-asserted-by":"publisher","first-page":"4103","DOI":"10.1200\/JCO.24.00427","article-title":"US food and drug administration approval summary: Capivasertib with fulvestrant for hormone receptor-positive, human epidermal growth factor receptor 2-negative locally advanced or metastatic breast cancer with PIK3CA\/ AKT1\/ PTEN alterations","volume":"42","author":"Dilawari","year":"2024","journal-title":"J. Clin. Oncol."},{"key":"2026102009504713200_bib17","doi-asserted-by":"publisher","first-page":"730","DOI":"10.1158\/2159-8290.CD-21-0385","article-title":"EP300 selectively controls the enhancer landscape of MYCN-amplified neuroblastoma","volume":"12","author":"Durbin","year":"2022","journal-title":"Cancer Discov."},{"key":"2026102009504713200_bib18","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1016\/j.cell.2024.12.005","article-title":"Ongoing chromothripsis underpins osteosarcoma genome complexity and clonal evolution","volume":"188","author":"Espejo Valle-Inclan","year":"2025","journal-title":"Cell"},{"key":"2026102009504713200_bib19","doi-asserted-by":"publisher","first-page":"558","DOI":"10.1038\/s41568-021-00380-y","article-title":"The plasticity of mRNA translation during cancer progression and therapy resistance","volume":"21","author":"Fabbri","year":"2021","journal-title":"Nat. Rev. Cancer"},{"key":"2026102009504713200_bib20","doi-asserted-by":"publisher","first-page":"1758835920922055","DOI":"10.1177\/1758835920922055","article-title":"Myc is a prognostic biomarker and potential therapeutic target in osteosarcoma","volume":"12","author":"Feng","year":"2020","journal-title":"Ther. Adv. Med. Oncol."},{"key":"2026102009504713200_bib21","doi-asserted-by":"publisher","first-page":"503","DOI":"10.1038\/s41586-019-1186-3","article-title":"Next-generation characterization of the cancer cell line Encyclopedia","volume":"569","author":"Ghandi","year":"2019","journal-title":"Nature"},{"key":"2026102009504713200_bib22","doi-asserted-by":"publisher","first-page":"6744","DOI":"10.3892\/ol.2017.6972","article-title":"Expression of NF-\u03baB and PTEN in osteosarcoma and its clinical significance","volume":"14","author":"Gong","year":"2017","journal-title":"Oncol. Lett."},{"key":"2026102009504713200_bib23","doi-asserted-by":"publisher","first-page":"518","DOI":"10.1002\/pbc.23412","article-title":"Testing of the Akt\/PKB inhibitor MK-2206 by the pediatric preclinical testing program","volume":"59","author":"Gorlick","year":"2012","journal-title":"Pediatr. Blood Cancer"},{"key":"2026102009504713200_bib24","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1101\/gad.352084.124","article-title":"mTORC1, the maestro of cell metabolism and growth","volume":"39","author":"He","year":"2025","journal-title":"Genes Dev."},{"key":"2026102009504713200_bib25","doi-asserted-by":"publisher","first-page":"110323","DOI":"10.1016\/j.celrep.2022.110323","article-title":"SIX1 reprograms myogenic transcription factors to maintain the rhabdomyosarcoma undifferentiated state","volume":"38","author":"Hsu","year":"2022","journal-title":"Cell Rep."},{"key":"2026102009504713200_bib26","doi-asserted-by":"publisher","first-page":"6592","DOI":"10.1128\/MCB.25.15.6592-6602.2005","article-title":"Akt phosphorylation of p300 at Ser-1834 is essential for its histone acetyltransferase and transcriptional activity","volume":"25","author":"Huang","year":"2005","journal-title":"Mol. Cell Biol."},{"key":"2026102009504713200_bib27","doi-asserted-by":"publisher","first-page":"1074","DOI":"10.1126\/science.1063127","article-title":"Translating the histone code","volume":"293","author":"Jenuwein","year":"2001","journal-title":"Science"},{"key":"2026102009504713200_bib28","doi-asserted-by":"publisher","first-page":"15056","DOI":"10.1021\/jacs.1c04432","article-title":"A dual-site inhibitor of CBP\/p300 KIX is a selective and effective modulator of Myb","volume":"143","author":"Joy","year":"2021","journal-title":"J. Am. Chem. Soc."},{"key":"2026102009504713200_bib29","doi-asserted-by":"publisher","first-page":"789","DOI":"10.1128\/MCB.26.3.789-809.2006","article-title":"Conditional knockout mice reveal distinct functions for the global transcriptional coactivators CBP and p300 in T-cell development","volume":"26","author":"Kasper","year":"2006","journal-title":"Mol. Cell. Biol."},{"key":"2026102009504713200_bib30","doi-asserted-by":"publisher","first-page":"357","DOI":"10.1038\/nmeth.3317","article-title":"HISAT: A fast spliced aligner with low memory requirements","volume":"12","author":"Kim","year":"2015","journal-title":"Nat. Methods"},{"key":"2026102009504713200_bib31","doi-asserted-by":"publisher","first-page":"8940","DOI":"10.1038\/ncomms9940","article-title":"Exome sequencing of osteosarcoma reveals mutation signatures reminiscent of BRCA deficiency","volume":"6","author":"Kovac","year":"2015","journal-title":"Nat. Commun."},{"key":"2026102009504713200_bib32","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1101\/gad.14.3.272","article-title":"Gene dose-dependent control of hematopoiesis and hematologic tumor suppression by CBP","volume":"14","author":"Kung","year":"2000","journal-title":"Genes Dev."},{"key":"2026102009504713200_bib33","doi-asserted-by":"publisher","first-page":"950","DOI":"10.1126\/science.1229386","article-title":"Precise maps of RNA polymerase reveal how promoters direct initiation and pausing","volume":"339","author":"Kwak","year":"2013","journal-title":"Science"},{"key":"2026102009504713200_bib34","doi-asserted-by":"publisher","first-page":"357","DOI":"10.1038\/nmeth.1923","article-title":"Fast gapped-read alignment with Bowtie 2","volume":"9","author":"Langmead","year":"2012","journal-title":"Nat. Methods"},{"key":"2026102009504713200_bib35","doi-asserted-by":"publisher","first-page":"R25","DOI":"10.1186\/gb-2009-10-3-r25","article-title":"Ultrafast and memory-efficient alignment of short DNA sequences to the human genome","volume":"10","author":"Langmead","year":"2009","journal-title":"Genome Biol."},{"key":"2026102009504713200_bib36","doi-asserted-by":"publisher","first-page":"128","DOI":"10.1038\/nature24028","article-title":"Discovery of a selective catalytic p300\/CBP inhibitor that targets lineage-specific tumours","volume":"550","author":"Lasko","year":"2017","journal-title":"Nature"},{"key":"2026102009504713200_bib37","doi-asserted-by":"publisher","first-page":"7332","DOI":"10.1038\/s41467-023-43134-0","article-title":"A CRISPR-drug perturbational map for identifying compounds to combine with commonly used chemotherapeutics","volume":"14","author":"Lee","year":"2023","journal-title":"Nat. Commun."},{"key":"2026102009504713200_bib38","doi-asserted-by":"publisher","first-page":"1754","DOI":"10.1093\/bioinformatics\/btp324","article-title":"Fast and accurate short read alignment with Burrows-Wheeler transform","volume":"25","author":"Li","year":"2009","journal-title":"Bioinformatics"},{"key":"2026102009504713200_bib39","doi-asserted-by":"crossref","first-page":"a026831","DOI":"10.1101\/cshperspect.a026831","article-title":"HDACs and HDAC inhibitors in cancer development and therapy","volume":"6","author":"Li","year":"2016","journal-title":"Cold Spring Harb Perspect. Med."},{"key":"2026102009504713200_bib40","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1039\/9781837674916-00266","article-title":"Chemical targeting of histone acetyltransferases","volume-title":"Epigenetic Drug Discovery","author":"Liu","year":"2024"},{"key":"2026102009504713200_bib41","doi-asserted-by":"publisher","first-page":"550","DOI":"10.1186\/s13059-014-0550-8","article-title":"Moderated estimation of fold change and dispersion for RNA-seq data with DESeq2","volume":"15","author":"Love","year":"2014","journal-title":"Genome Biol."},{"key":"2026102009504713200_bib42","doi-asserted-by":"publisher","first-page":"140","DOI":"10.1038\/s42003-020-0868-6","article-title":"Extended pharmacodynamic responses observed upon PROTAC-mediated degradation of RIPK2","volume":"3","author":"Mares","year":"2020","journal-title":"Commun. Biol."},{"key":"2026102009504713200_bib43","doi-asserted-by":"publisher","first-page":"285","DOI":"10.1038\/nrg2752","article-title":"Chromatin structure and the inheritance of epigenetic information","volume":"11","author":"Margueron","year":"2010","journal-title":"Nat. Rev. Genet."},{"key":"2026102009504713200_bib44","doi-asserted-by":"publisher","first-page":"1396","DOI":"10.1016\/S1470-2045(16)30214-5","article-title":"Comparison of MAPIE versus MAP in patients with a poor response to preoperative chemotherapy for newly diagnosed high-grade osteosarcoma (EURAMOS-1): An open-label, international, randomised controlled trial","volume":"17","author":"Marina","year":"2016","journal-title":"Lancet Oncol."},{"key":"2026102009504713200_bib45","doi-asserted-by":"publisher","DOI":"10.1200\/PO.22.00334","article-title":"Clinical targeted next-generation panel sequencing reveals MYC amplification is a poor prognostic factor in osteosarcoma","volume":"7","author":"Marinoff","year":"2023","journal-title":"JCO Precis Oncol."},{"key":"2026102009504713200_bib46","doi-asserted-by":"publisher","first-page":"2049","DOI":"10.1039\/d4md00969j","article-title":"Development of p300-targeting degraders with enhanced selectivity and onset of degradation","volume":"16","author":"Marsh","year":"2025","journal-title":"RSC Med. Chem."},{"key":"2026102009504713200_bib47","doi-asserted-by":"publisher","first-page":"2349","DOI":"10.1073\/pnas.1311846111","article-title":"High-throughput combinatorial screening identifies drugs that cooperate with ibrutinib to kill activated B-cell-like diffuse large B-cell lymphoma cells","volume":"111","author":"Mathews Griner","year":"2014","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"2026102009504713200_bib48","first-page":"716","article-title":"Estrogen receptor analyses. Correlation of biochemical and immunohistochemical methods using monoclonal antireceptor antibodies","volume":"109","author":"McCarty","year":"1985","journal-title":"Arch. Pathol. Lab. Med."},{"key":"2026102009504713200_bib49","doi-asserted-by":"publisher","first-page":"2066","DOI":"10.1056\/NEJMra2103423","article-title":"New horizons in the treatment of osteosarcoma","volume":"385","author":"Meltzer","year":"2021","journal-title":"N. Engl. J. Med."},{"key":"2026102009504713200_bib50","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1021\/acsmedchemlett.7b00395","article-title":"Discovery of spiro oxazolidinediones as selective, orally bioavailable inhibitors of p300\/CBP histone acetyltransferases","volume":"9","author":"Michaelides","year":"2018","journal-title":"ACS Med. Chem. Lett."},{"key":"2026102009504713200_bib51","doi-asserted-by":"publisher","first-page":"1565","DOI":"10.1001\/jamaoncol.2016.0891","article-title":"Landscape of phosphatidylinositol-3-kinase pathway alterations across 19 784 diverse solid tumors","volume":"2","author":"Millis","year":"2016","journal-title":"JAMA Oncol."},{"key":"2026102009504713200_bib52","doi-asserted-by":"publisher","first-page":"176","DOI":"10.1038\/nm.4475","article-title":"Positively selected enhancer elements endow osteosarcoma cells with metastatic competence","volume":"24","author":"Morrow","year":"2018","journal-title":"Nat. Med."},{"key":"2026102009504713200_bib53","doi-asserted-by":"publisher","first-page":"2166","DOI":"10.1016\/j.molcel.2021.03.008","article-title":"Enhancers are activated by p300\/CBP activity-dependent PIC assembly, RNAPII recruitment, and pause release","volume":"81","author":"Narita","year":"2021","journal-title":"Mol. Cell"},{"key":"2026102009504713200_bib54","doi-asserted-by":"publisher","first-page":"430","DOI":"10.1158\/2159-8290.CD-15-0754","article-title":"Targeting p300 addiction in CBP-deficient cancers causes synthetic lethality by apoptotic cell death due to abrogation of MYC expression","volume":"6","author":"Ogiwara","year":"2016","journal-title":"Cancer Discov."},{"key":"2026102009504713200_bib55","doi-asserted-by":"publisher","first-page":"953","DOI":"10.1016\/s0092-8674(00)82001-2","article-title":"The transcriptional coactivators p300 and CBP are histone acetyltransferases","volume":"87","author":"Ogryzko","year":"1996","journal-title":"Cell"},{"key":"2026102009504713200_bib56","doi-asserted-by":"publisher","first-page":"E5564","DOI":"10.1073\/pnas.1419260111","article-title":"Complementary genomic approaches highlight the PI3K\/mTOR pathway as a common vulnerability in osteosarcoma","volume":"111","author":"Perry","year":"2014","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"2026102009504713200_bib57","doi-asserted-by":"publisher","first-page":"110","DOI":"10.1038\/s41467-017-02618-6","article-title":"Peptidomimetic blockade of MYB in acute myeloid leukemia","volume":"9","author":"Ramaswamy","year":"2018","journal-title":"Nat. Commun."},{"key":"2026102009504713200_bib58","doi-asserted-by":"publisher","first-page":"5396","DOI":"10.1093\/nar\/gkq184","article-title":"Genome-wide assessment of differential roles for p300 and CBP in transcription regulation","volume":"38","author":"Ramos","year":"2010","journal-title":"Nucleic Acids Res."},{"key":"2026102009504713200_bib59","doi-asserted-by":"publisher","first-page":"14789","DOI":"10.1073\/pnas.232568499","article-title":"Distinct roles for CREB-binding protein and p300 in hematopoietic stem cell self-renewal","volume":"99","author":"Rebel","year":"2002","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"2026102009504713200_bib60","first-page":"138","article-title":"[Recommendation for uniform definition of an immunoreactive score (IRS) for immunohistochemical estrogen receptor detection (ER-ICA) in breast cancer tissue]","volume":"8","author":"Remmele","year":"1987","journal-title":"Pathologe"},{"key":"2026102009504713200_bib61","doi-asserted-by":"publisher","first-page":"btac830","DOI":"10.1093\/bioinformatics\/btac830","article-title":"igv.js: an embeddable JavaScript implementation of the Integrative Genomics Viewer (IGV)","volume":"39","author":"Robinson","year":"2023","journal-title":"Bioinformatics"},{"key":"2026102009504713200_bib62","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1158\/2159-8290.CD-17-1152","article-title":"Genome-informed targeted therapy for osteosarcoma","volume":"9","author":"Sayles","year":"2019","journal-title":"Cancer Discov."},{"key":"2026102009504713200_bib63","doi-asserted-by":"publisher","first-page":"282","DOI":"10.1016\/j.cels.2018.03.003","article-title":"Pan-cancer alterations of the MYC oncogene and its proximal network across the cancer genome Atlas","volume":"6","author":"Schaub","year":"2018","journal-title":"Cell Syst."},{"key":"2026102009504713200_bib64","doi-asserted-by":"publisher","first-page":"849","DOI":"10.1158\/1078-0432.CCR-23-0873","article-title":"Osteosarcoma PDX-derived cell line models for preclinical drug evaluation demonstrate metastasis inhibition by Dinaciclib through a genome-targeted approach","volume":"30","author":"Schott","year":"2024","journal-title":"Clin. Cancer Res."},{"key":"2026102009504713200_bib65","doi-asserted-by":"publisher","first-page":"101082","DOI":"10.1016\/j.xgen.2025.101082","article-title":"Analysis of error profiles of indels and structural variants in deep-sequencing data","volume":"6","author":"Shao","year":"2026","journal-title":"Cell Genom"},{"key":"2026102009504713200_bib66","doi-asserted-by":"publisher","first-page":"3483","DOI":"10.1038\/s41467-024-47102-0","article-title":"Group 3 medulloblastoma transcriptional networks collapse under domain specific EP300\/CBP inhibition","volume":"15","author":"Shendy","year":"2024","journal-title":"Nat. Commun."},{"key":"2026102009504713200_bib67","doi-asserted-by":"publisher","first-page":"96","DOI":"10.1038\/nature23647","article-title":"Orthotopic patient-derived xenografts of paediatric solid tumours","volume":"549","author":"Stewart","year":"2017","journal-title":"Nature"},{"key":"2026102009504713200_bib68","doi-asserted-by":"publisher","first-page":"15545","DOI":"10.1073\/pnas.0506580102","article-title":"Gene set enrichment analysis: A knowledge-based approach for interpreting genome-wide expression profiles","volume":"102","author":"Subramanian","year":"2005","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"2026102009504713200_bib69","doi-asserted-by":"publisher","first-page":"178","DOI":"10.1093\/bib\/bbs017","article-title":"Integrative genomics Viewer (IGV): High-performance genomics data visualization and exploration","volume":"14","author":"Thorvaldsdottir","year":"2013","journal-title":"Brief. Bioinform."},{"key":"2026102009504713200_bib70","doi-asserted-by":"publisher","first-page":"3131","DOI":"10.1242\/dev.037127","article-title":"CBP-mediated acetylation of histone H3 lysine 27 antagonizes Drosophila Polycomb silencing","volume":"136","author":"Tie","year":"2009","journal-title":"Development"},{"key":"2026102009504713200_bib71","doi-asserted-by":"publisher","first-page":"503","DOI":"10.1016\/j.chembiol.2020.12.004","article-title":"Targeted degradation of the enhancer lysine acetyltransferases CBP and p300","volume":"28","author":"Vannam","year":"2021","journal-title":"Cell Chem. Biol."},{"key":"2026102009504713200_bib72","doi-asserted-by":"publisher","first-page":"471","DOI":"10.1038\/s41571-022-00633-1","article-title":"At a crossroads: How to translate the roles of PI3K in oncogenic and metabolic signalling into improvements in cancer therapy","volume":"19","author":"Vasan","year":"2022","journal-title":"Nat. Rev. Clin. Oncol."},{"key":"2026102009504713200_bib73","doi-asserted-by":"publisher","first-page":"652","DOI":"10.1038\/nmeth.1628","article-title":"CREST maps somatic structural variation in cancer genomes with base-pair resolution","volume":"8","author":"Wang","year":"2011","journal-title":"Nat. Methods"},{"key":"2026102009504713200_bib74","doi-asserted-by":"publisher","first-page":"1019","DOI":"10.1016\/j.cell.2009.06.049","article-title":"Genome-wide mapping of HATs and HDACs reveals distinct functions in active and inactive genes","volume":"138","author":"Wang","year":"2009","journal-title":"Cell"},{"key":"2026102009504713200_bib75","doi-asserted-by":"publisher","first-page":"231","DOI":"10.1016\/j.cell.2018.04.033","article-title":"Time-resolved analysis reveals rapid dynamics and broad scope of the CBP\/p300 acetylome","volume":"174","author":"Weinert","year":"2018","journal-title":"Cell"},{"key":"2026102009504713200_bib76","doi-asserted-by":"publisher","first-page":"1118","DOI":"10.1158\/2159-8290.CD-20-0751","article-title":"Targeting the p300\/CBP Axis in lethal prostate cancer","volume":"11","author":"Welti","year":"2021","journal-title":"Cancer Discov."},{"key":"2026102009504713200_bib77","doi-asserted-by":"publisher","first-page":"307","DOI":"10.1016\/j.cell.2013.03.035","article-title":"Master transcription factors and mediator establish super-enhancers at key cell identity genes","volume":"153","author":"Whyte","year":"2013","journal-title":"Cell"},{"key":"2026102009504713200_bib78","doi-asserted-by":"publisher","first-page":"1086","DOI":"10.1016\/j.molcel.2020.04.023","article-title":"Using chemical epigenetics to target cancer","volume":"78","author":"Wimalasena","year":"2020","journal-title":"Mol. Cell"},{"key":"2026102009504713200_bib79","doi-asserted-by":"publisher","first-page":"419","DOI":"10.1038\/nbt.3460","article-title":"High-throughput identification of genotype-specific cancer vulnerabilities in mixtures of barcoded tumor cell lines","volume":"34","author":"Yu","year":"2016","journal-title":"Nat. Biotechnol."},{"key":"2026102009504713200_bib80","doi-asserted-by":"crossref","first-page":"820","DOI":"10.1016\/j.ccell.2017.04.013","article-title":"A Pan-cancer proteogenomic Atlas of PI3K\/AKT\/mTOR pathway alterations","volume":"31","author":"Zhang","year":"2017","journal-title":"Cancer Cell"},{"key":"2026102009504713200_bib81","doi-asserted-by":"publisher","first-page":"R137","DOI":"10.1186\/gb-2008-9-9-r137","article-title":"Model-based analysis of ChIP-seq (MACS)","volume":"9","author":"Zhang","year":"2008","journal-title":"Genome Biol."},{"key":"2026102009504713200_bib82","doi-asserted-by":"crossref","first-page":"BSR20190954","DOI":"10.1042\/BSR20190954","article-title":"Association between PTEN and clinical-pathological features of osteosarcoma","volume":"39","author":"Zhou","year":"2019","journal-title":"Biosci. Rep."},{"key":"2026102009504713200_bib83","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1038\/s41573-024-01080-6","article-title":"Targeting lysine acetylation readers and writers","volume":"24","author":"Zhou","year":"2025","journal-title":"Nat. Rev. Drug Discov."},{"key":"2026102009504713200_bib84","doi-asserted-by":"publisher","first-page":"2133","DOI":"10.1021\/acs.biochem.9b00160","article-title":"Combination targeting of the bromodomain and acetyltransferase active site of p300\/CBP","volume":"58","author":"Zucconi","year":"2019","journal-title":"Biochemistry"}],"container-title":["Journal of Experimental Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/rupress.org\/jem\/article-pdf\/doi\/10.1084\/jem.20251898\/2042413\/jem_20251898.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/rupress.org\/jem\/article-pdf\/doi\/10.1084\/jem.20251898\/2042413\/jem_20251898.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,20]],"date-time":"2026-10-20T13:51:10Z","timestamp":1792504270000},"score":1,"resource":{"primary":{"URL":"https:\/\/rupress.org\/jem\/article\/223\/11\/e20251898\/283094\/Dysregulated-AKT-signaling-reprograms-osteosarcoma"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,10,20]]},"references-count":84,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2026,11,2]]}},"URL":"https:\/\/doi.org\/10.1084\/jem.20251898","relation":{},"ISSN":["0022-1007","1540-9538"],"issn-type":[{"value":"0022-1007","type":"print"},{"value":"1540-9538","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,10,20]]},"article-number":"e20251898"}}